Physician profile
Michael J Dorsi
NPI 1942355854
$616,762.34
in general payments reported to CMS, 2019-2025
49 companies · $63K in 2025
The $63K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88K · 2020: $79K · 2021: $67K · 2022: $117K · 2023: $104K · 2024: $99K · 2025: $63K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $121K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Travel and Lodging: $31K · Food and Beverage: $29K · Royalty Or License: $17K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $16K · Education: $15K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $121,231.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,643.14 |
| Travel and Lodging | $31,332.59 |
| Food and Beverage | $28,500.70 |
| Royalty Or License | $17,249.16 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $16,293.75 |
| Education | $14,670.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $202,959.96 | 2019-2024 | Senza, Vyrsa V1, Omnia |
| The Institute of Musculoskeletal Science and Education | $95,471.35 | 2019-2025 | Spira |
| Abbott Laboratories | $79,651.61 | 2019-2025 | Proclaim, Eterna, Penta |
| Nuvasive, INC. | $68,048.07 | 2019-2023 | Xlif, Alif, Modulus |
| Globus Medical, INC. | $39,277.48 | 2020-2025 | Creo Mcs, Fenestrated, Sideloading, Vyrsa V1, Senza |
| Ferring Pharmaceuticals INC. | $33,051.60 | 2023-2025 | Euflexxa |
| Painteq LLC | $21,488.08 | 2022-2025 | Painteq |
| Life Spine, INC. | $13,769.76 | 2021-2023 | Centric-S |
| Saluda Medical Americas, INC. | $13,152.17 | 2022-2025 | Evoke, Evoke Scs |
| Biotronik Nro, INC. | $9,347.42 | 2023-2025 | Prospera, Biotronik |
| Depuy Synthes Sales INC. | $9,306.95 | 2019-2025 | Velys, Synthecel, Matrixneuro |
| Boston Scientific Corporation | $8,952.73 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Biotronik INC. | $5,538.03 | 2021-2025 | Prospera |
| Camber Spine Technologies LLC | $5,416.72 | 2020-2023 | |
| Centinel Spine, LLC | $3,727.58 | 2019-2022 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $1,654.63 | 2020 | |
| Saxum Surgical, INC. | $749.86 | 2024 | |
| Arthrex, INC. | $581.35 | 2024 | |
| Medtronic, INC. | $563.66 | 2023-2025 | Accurian, Inceptiv, Intellis Adaptivestim |
| Spr Therapeutics, INC | $549.62 | 2022-2025 | Sprint Pns System |
| Relievant Medsystems, INC. | $444.07 | 2021-2023 | Intracept |
| Mml US, INC. | $398.56 | 2023-2025 | Reactiv8 |
| Nalu Medical, INC. | $229.20 | 2021-2025 | Nalu Neurostimulation System |
| Si-Bone, INC. | $210.37 | 2022-2023 | |
| Ulrich Medical USA, INC. | $205.47 | 2023-2024 | |
| Spineart USA INC | $197.65 | 2022-2025 | |
| Highridge Medical LLC | $187.19 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Vertos Medical, INC. | $185.74 | 2023 | Mild Device Kit |
| Choice Spine, LLC | $163.42 | 2024 | Triton, Veo Lateral Interbody Fusion System, Stratofuse |
| Cerapedics INC. | $156.58 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Zimvie INC. | $150.84 | 2023 | |
| Providence Medical Technology, INC. | $132.59 | 2025 | |
| Medical Device Business Services, INC. | $124.42 | 2020 | |
| Spineology INC. | $98.65 | 2025 | |
| Neo Spine USA, INC. | $97.58 | 2025 | Neo Pedicle Screw System |
| Intrinsic Therapeutics | $79.50 | 2025 | Barricaid Acd (Annular Closure Device) |
| Carlsmed, INC. | $61.84 | 2025 | Aprevo |
| Abbvie INC. | $61.25 | 2023-2025 | Botox |
| Orthofix Medical, INC. | $54.42 | 2025 | Spinal-Stim |
| Axogen | $51.57 | 2022 | |
| Ebi, LLC | $43.02 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Stryker Corporation | $41.10 | 2020 | |
| Spineguard, INC. | $35.02 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $20.13 | 2025 | Exparel |
| Stimwave Technologies Incorporated | $18.64 | 2020 | |
| Arbor Pharmaceuticals, INC. | $16.26 | 2021 | |
| Amgen INC. | $14.06 | 2025 | Prolia, Evenity |
| Medtronic USA, INC. | $13.62 | 2020 | |
| Foundation Fusion Solutions, LLC | $10.95 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dorsi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.